SCHEMBL4724840

SCHEMBL4724840

CCNc1[c]nc2ccccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 5/20 0.39
ACHE P22303 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
MAPT P10636 2/20 0.38
GLA P06280 1/20 0.38
ELANE P08246 1/20 0.36
POLB P06746 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
KMT2A Q03164 1/20 0.36
APP P05067 2/20 0.35
BCHE P06276 2/20 0.35
CYP1A2 P05177 2/20 0.34
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
STAT3 P40763 2/20 0.33
PGK1 P00558 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4720683 0.87 TLR8 (0.43) TLR8ACHEALDH1A1HPGDMAPT
SCHEMBL4722779 0.84 TLR8 (0.55) TLR8ALDH1A1ELANESMN1; SMN2NPC1
SCHEMBL4723728 0.82 NCF1 (0.44) TLR8ACHEALDH1A1HPGDMAPT
SCHEMBL4724189 0.79 ELANE (0.35) TLR8ACHEALDH1A1HPGDMAPT
SCHEMBL4721803 0.78 ELANE (0.42) TLR8ALDH1A1MAPTGLAELANE
SCHEMBL9637930 0.77 ALDH1A1 (0.41) ACHEALDH1A1HPGDMAPTGLA
SCHEMBL4722347 0.76 KCNH2 (0.40) TLR8
SCHEMBL4724624 0.76 APP (0.41) TLR8ACHEALDH1A1HPGDMAPT
SCHEMBL4724625 0.75 TLR8 (0.43) TLR8HPGDELANESMN1; SMN2GAA
SCHEMBL4719858 0.74 CACNA2D1 (0.37) TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 TLR8 1678/4885ACHE 626/4885ALDH1A1 622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.